1-4 of 4
Roberto Calcedo
Close
Sort by
Journal Articles

Immune Responses in 101HEMB01, a Phase 1/2 Open-Label, Single Ascending Dose-Finding Trial of DTX101 (AAVrh10FIX) in Patients with Severe Hemophilia B

Roberto Calcedo, Leticia Kuri-Cervantes, Hui Peng, Qiuyue Qin, Surina Boyd, Mark Schneider, Matt Hewitt, Michael Betts, James Wilson, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3333.
https://doi.org/10.1182/blood.V130.Suppl_1.3333.3333
Published: 2017
Journal Articles

Strategies for Selection of AAV Vectors for Administration to Liver: Studies in Nonhuman Primates

Lili Wang, PhD, James M Wilson, MD PhD, Roberto Calcedo, PhD, Peter Bell, PhD, Zhenning He, John White, Matthew Hewitt, Leah Makaron, DVM, Lisa Kattenhorn, VMD, PhD DACVP, Sam Wadsworth, PhD, Tamara Goode, DVM, DACLAM
Journal: Blood
Blood (2016) 128 (22): 2316.
https://doi.org/10.1182/blood.V128.22.2316.2316
Published: 2016
Journal Articles

Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy

Lili Wang, Roberto Calcedo, Timothy C. Nichols, Dwight A. Bellinger, Aaron Dillow, Inder M. Verma, James M. Wilson
Journal: Blood
Blood (2005) 105 (8): 3079–3086.
https://doi.org/10.1182/blood-2004-10-3867
Published: 2005
Journal Articles

Erythropoietin gene therapy leads to autoimmune anemia in macaques

Brief Report
Guangping Gao, Corinna Lebherz, Daniel J. Weiner, Rebecca Grant, Roberto Calcedo, Beth McCullough, Adam Bagg, Yi Zhang, James M. Wilson
Journal: Blood
Blood (2004) 103 (9): 3300–3302.
https://doi.org/10.1182/blood-2003-11-3852
Published: 2004